Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.43 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28986897 | 0.98 | THRB (0.42) | THRBCHRM2CHRM4CHRM5CHRM1 | |
| Water SCHEMBL28394473 | 0.98 | THRB (0.42) | THRBCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL28478533 | 0.94 | THRB (0.46) | THRBCHRM2CHRM4CHRM5CHRM1 | |
| Methanesulfonic Acid Methyl Ester SCHEMBL28802093 | 0.92 | THRB (0.44) | THRBCHRM2CHRM4CHRM5CHRM1 | |
| Sulfuric Acid SCHEMBL3785079 | 0.91 | THRB (0.47) | THRBCHRM2CHRM4CHRM5CHRM1 | |
| Sulfuric Acid SCHEMBL127383 | 0.91 | THRB (0.47) | THRBCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL28669377 | 0.90 | TSHR (0.47) | THRBCHRM2CHRM4CHRM5CHRM1 | |
| Acrylamide SCHEMBL10524522 | 0.90 | THRB (0.36) | THRBCHRM2CHRM4CHRM5CHRM1 | |
| Sulfuric Acid Dimethyl Ester SCHEMBL4810305 | 0.90 | THRB (0.43) | THRBCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL29221412 | 0.90 | THRB (0.43) | THRBCHRM2CHRM4CHRM5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 774 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739418-A2 | ONE-PASS DEOXYGENATION METHOD FOR POLYACRYLAMIDE PRODUCTION | KEMIRA OYJ (FI) | 2026-05-13 | — | — | EP | claimed |
| EP-4728136-A1 | STRENGTH SYNERGY BETWEEN POLYMER AND PAPERMAKING STRENGTH AID | Ecolab USA, Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4716777-A2 | USE OF AMPHOTERIC EMULSION POLYMERS WITH STRENGTH RESINS AS RETENTION AND DRAINAGE AIDS | KEMIRA OYJ (FI) | 2026-04-01 | — | — | EP | claimed |
| US-12553188-B2 | GPAM compositions and methods | KEMIRA OYJ (FI) | 2026-02-17 | — | — | US | claimed |
| EP-4683950-A1 | DUAL EMULSIFICATION OF ALKENYL SUCCINIC ANHYDRIDE TO IMPROVE SIZING PERFORMANCE AND STABILITY | KEMIRA OYJ (FI) | 2026-01-28 | — | — | EP | claimed |
| US-20250215649-A1 | HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYSACCHARIDE PROMOTER | KEMIRA OYJ (FI) | 2025-07-03 | — | — | US | claimed |
| US-20250137200-A1 | HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYMERIC PROMOTER | KEMIRA OYJ (FI) | 2025-05-01 | — | — | US | claimed |
| EP-4256009-B1 | OIL-IN-WATER EMULSIONS | QUADRISE INT LTD (GB) | 2025-04-09 | — | — | EP | claimed |
| WO-2025072390-A1 | USE OF QUICK INVERSION CATIONIC EMULSION POLYMERS WITH POLYVINYLAMINES AS RETENTION AND DRAINAGE AIDS | KEMIRA OYJ (FI) | 2025-04-03 | — | — | WO | claimed |
| WO-2025015262-A2 | ONE-PASS DEOXYGENATION METHOD FOR POLYACRYLAMIDE PRODUCTION | KEMIRA OYJ (FI) | 2025-01-16 | — | — | WO | claimed |
| US-20040058606-A1 | Ion triggerable, cationic polymers, a method of making same and items using same | KIMBERLY-CLARK WORLDWIDE, INC. | 2004-03-25 | — | — | US | claimed |
| US-20040055704-A1 | Ion triggerable, cationic polymers, a method of making same and items using same | KIMBERLY-CLARK WORLDWIDE, INC. | 2004-03-25 | — | — | US | claimed |
| US-6645428-B1 | Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems | ONDEO NALCO COMPANY | 2003-11-11 | — | — | US | claimed |
| EP-1282732-A1 | FLUORESCENT MONOMERS AND TAGGED TREATMENT POLYMERS CONTAINING SAME FOR USE IN INDUSTRIAL WATER SYSTEMS | Ondeo Nalco Company (US) | 2003-02-12 | — | — | EP | claimed |
| US-6344531-B1 | Fluorescent water-soluble polymers | NALCO CHEMICAL COMPANY | 2002-02-05 | — | — | US | claimed |
| WO-2001081654-A1 | FLUORESCENT MONOMERS AND TAGGED TREATMENT POLYMERS CONTAINING SAME FOR USE IN INDUSTRIAL WATER SYSTEMS | ONDEO NALCO COMPANY (US) | 2001-11-01 | — | — | WO | claimed |
| US-4929687-A | ACRYLAMIDE AND METHACRYLAMIDE CATIONIC COPOLYMERS | AMERICAN CYANAMID COMPANY (US) | 1990-05-29 | — | — | US | claimed |
| US-4785055-A | REACTION WITH HALIDE OR HYPOHALITES | AMERICAN CYANAMID COMPANY (US) | 1988-11-15 | — | — | US | claimed |
| EP-0245702-A2 | Polymers, paper of high wet-strength and processes of making same | AMERICAN CYANAMID COMPANY (US) | 1987-11-19 | — | — | EP | claimed |
| CN-86108760-A | Polymer gel is rapidly-soluble method in water | — | 1987-10-07 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12553188-B2 | GPAM compositions and methods | PGM2, SLC6A9, GNMT | CHRM1 848/4885CHRM3 1722/4885THRB 4162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.